Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer
- PMID: 21619050
- PMCID: PMC3127263
- DOI: 10.1021/bi200642e
Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer
Abstract
P16(INK4A) (also known as P16 and MTS1), a protein consisting exclusively of four ankyrin repeats, is recognized as a tumor suppressor mainly because of the prevalence of genetic inactivation of the p16(INK4A) (or CDKN2A) gene in virtually all types of human cancers. However, it has also been shown that an elevated level of expression (upregulation) of P16 is involved in cellular senescence, aging, and cancer progression, indicating that the regulation of P16 is critical for its function. Here, we discuss the regulatory mechanisms of P16 function at the DNA level, the transcription level, and the posttranscriptional level, as well as their implications for the structure-function relationship of P16 and for human cancers.
Figures
References
-
- Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumor suppressor locus: all for one or one for all. Nature Reviews. 2006;7:667–677. - PubMed
-
- Sharpless NE. INK4a/ARF: A multifunctional tumor suppressor locus. Mut Res. 2005;576:22–38. - PubMed
-
- Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007;130:223–233. - PubMed
-
- Kim WY, Sharpless NE. The regulation of INK4/ARF in cancer and aging. Cell. 2006;127:265–275. - PubMed
-
- Sherr CJ, Roberts JM. Living with or without cyclins and cyclin-dependent kinases. Genes Dev. 2004;18:2699–2711. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
